Recombinant DNA Technology Market Size $274.52 Billion by 2030
Report Overview:
The Global Recombinant DNA Technology Market achieved a valuation of $152.79 Billion in 2022 and is anticipated to exceed $274.52 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 7.6% during the forecast period from 2024 to 2032.
Key Market Players:
F. Hoffmann-La Roche Ltd (Genentech Inc), Profacgen, Amgen Inc, Novartis AG, GenScript, Pfizer...
0 Comments
0 Shares